First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer. Supplementary material
figure
posted on 2022-06-13, 09:22 authored by Andrea Messori, L Di Spazio, Marco Chiumente, Luca Cancanelli, Melania Rivano, Daniele MengatoFigure 1S. Literature search according to the PRISMA diagram.
Figure 2S. Results of NETMA according to fixed-effect model.
